Income Taxes (Details Narrative) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Tax Credit Carryforward [Line Items] | ||
| Deferred Income Tax Expense (Benefit) | $ 0 | |
| Income Tax Paid, before Refund Received | 0 | |
| Deferred Tax Assets, Valuation Allowance | (115,932) | $ (102,655) |
| Change in Valuation Allowance | 13,300 | |
| Federal Net Operating Loss Carryforward | 244,400 | |
| State net operating loss carryforwards | $ 2,200 | |
| Tax Credit Carryforward, Limitations on Use | The federal net operating loss and approximately $1.1 million of state net operating losses can be carried forward indefinitely, subject to an 80% limitation against taxable income. The remaining state net operating losses of approximately $1.1 million will begin to expire in 2042, unless previously utilized. | |
| Tax Credit Carryforward, Amount | $ 11,800 | |
| Tax Credit Carryforward Expiration Period | 2040 years | |
| Orphan Drug Credit | $ 5,600 | |
| Orphan drug credit carryforwards Expiration Period | 2041 years | |
| Use of annual operating loss carryforwards | Sections 382 and 383, annual use of the Company’s net operating loss carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period. | |
| Research Tax Credit Carryforward [Member] | ||
| Tax Credit Carryforward [Line Items] | ||
| Tax Credit Carryforward, Amount | $ 4,000 |